Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRK6 | P43250 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | HK1 | P19367 | 1/20 | 0.30 |
| ▸ | HK2 | P52789 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL393237 | 0.74 | — | — | |
| SCHEMBL1607814 | 0.74 | — | — | |
| SCHEMBL6293001 | 0.74 | — | — | |
| SCHEMBL26449 | 0.74 | — | — | |
| SCHEMBL2152717 | 0.74 | — | — | |
| SCHEMBL348997 | 0.74 | — | — | |
| SCHEMBL329683 | 0.74 | — | — | |
| SCHEMBL25344469 | 0.72 | LGALS1 (0.37) | ALDH1A1 | |
| SCHEMBL16751799 | 0.72 | LGALS1 (0.37) | ALDH1A1 | |
| Hydrogen Sulfide SCHEMBL1233863 | 0.72 | ALDH1A1 (0.33) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4683222-A | STIMULANTS FOR IMMUNE SYSTEM | BAYER AKTIENGESELLSCHAFT (DE) | 1987-07-28 | — | — | US | claimed |
| US-20090182133-A1 | BENZOPYRANONE DERIVATIVES AND THEIR USE AS ANTI-VIRAL AGENTS | SINGAPORE POLYTECHNIC | 2009-07-16 | — | — | US | disclosed |
| US-5872111-A | TOILET BAR SOAP, FACIAL BODY CLEANSER, SHAMPOO, CONDITIONER, COSMETIC,SHAVING CREAM OR LOTION, SHOWER GEL, FABRIC SOFTENING CONDITIONER, AND UNDERARM DEODORANT/ANTI-PERSPIRANT | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1999-02-16 | — | — | US | disclosed |
| US-4737488-A | Immune system-stimulating N-glycosylated ureas and carbamates | BAYER AKTIENGESELLSCHAFT (DE) | 1988-04-12 | — | — | US | disclosed |
| US-4710491-A | N-glycosylated carboxylic acid derivatives as agents for combating rheumatic diseases | TROPONWERKE GMBH & CO., KG (DE) | 1987-12-01 | — | — | US | disclosed |
| US-4683222-A | STIMULANTS FOR IMMUNE SYSTEM | BAYER AKTIENGESELLSCHAFT (DE) | 1987-07-28 | — | — | US | disclosed |
| US-4680287-A | N-glycosylated carboxamide derivatives as growth-promoters in livestock feeding | BAYER AKTIENGESELLSCHAFT (DE) | 1987-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090182133-A1 | BENZOPYRANONE DERIVATIVES AND THEIR USE AS ANTI-VIRAL AGENTS | SARS1, MAVS, ACE2 | GRK6 431/4885CYP1A2 819/4885NFKB1 250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.